Maximus (NYSE:MMS) Cut to Hold at Wall Street Zen

Wall Street Zen cut shares of Maximus (NYSE:MMS) from a buy rating to a hold rating in a research report released on Monday.

Other equities analysts also recently issued reports about the stock. Weiss Ratings reissued a “buy (b-)” rating on shares of Maximus in a report on Monday, December 29th. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the stock. Based on data from MarketBeat.com, Maximus has an average rating of “Strong Buy”.

Maximus Price Performance

Maximus stock opened at $74.10 on Monday. Maximus has a 52 week low of $63.77 and a 52 week high of $100.00. The company’s 50 day moving average price is $87.28 and its two-hundred day moving average price is $86.49. The stock has a market cap of $4.04 billion, a P/E ratio of 11.28 and a beta of 0.57. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.01. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.37 billion. Maximus had a return on equity of 25.30% and a net margin of 6.92%.Maximus’s revenue was down 4.1% on a year-over-year basis. During the same period last year, the business posted $1.61 earnings per share. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, equities analysts predict that Maximus will post 6.15 earnings per share for the current year.

Maximus Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Friday, February 13th will be paid a $0.33 dividend. The ex-dividend date is Friday, February 13th. This represents a $1.32 dividend on an annualized basis and a yield of 1.8%. This is a positive change from Maximus’s previous quarterly dividend of $0.30. Maximus’s dividend payout ratio (DPR) is presently 20.09%.

Insider Buying and Selling at Maximus

In other news, CFO David Mutryn acquired 1,000 shares of Maximus stock in a transaction that occurred on Monday, February 9th. The stock was bought at an average price of $75.62 per share, with a total value of $75,620.00. Following the completion of the purchase, the chief financial officer owned 40,037 shares in the company, valued at approximately $3,027,597.94. The trade was a 2.56% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Michelle F. Link sold 4,039 shares of the firm’s stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the completion of the transaction, the insider directly owned 19,542 shares of the company’s stock, valued at approximately $1,697,027.28. The trade was a 17.13% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have acquired 4,231 shares of company stock valued at $329,521 in the last 90 days. 1.80% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in MMS. Royal Bank of Canada grew its position in Maximus by 146.2% during the first quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock worth $1,345,000 after buying an additional 11,716 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after purchasing an additional 221 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Maximus by 7.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock worth $12,321,000 after purchasing an additional 11,754 shares during the last quarter. Jane Street Group LLC raised its stake in Maximus by 941.2% in the first quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock valued at $6,701,000 after purchasing an additional 88,835 shares in the last quarter. Finally, Sivia Capital Partners LLC purchased a new stake in Maximus in the second quarter valued at approximately $204,000. Institutional investors own 97.21% of the company’s stock.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.